Increased risk of osteoporotic fractures and osteoporosis in patients with Addison's disease in Sweden: A nationwide population‐based cohort study
The risk of MOF is increased in patients with AAD without any apparent correlation to adrenal hormone replacement doses.
Authors
- Tim Spelman (ORCID: https://orcid.org/0000-0001-9204-3216)
- Jakob Skov (ORCID: https://orcid.org/0000-0002-3738-1367)
- Sophie Bensing (ORCID: https://orcid.org/0000-0002-9193-2860)
- Sara Öster (ORCID: https://orcid.org/0000-0003-3610-6176)
- Daniel Eriksson (ORCID: https://orcid.org/0000-0001-5473-3312)
- Olle Kämpe (ORCID: https://orcid.org/0000-0001-6091-9914)
- Stavros Stergianos (ORCID: https://orcid.org/0000-0003-3476-3287)
- Sigríður Björnsdóttir (ORCID: https://orcid.org/0000-0002-3320-5972)
Institutions
- Uppsala University (SE)
- Karolinska University Hospital (SE)
- Karolinska Institutet (SE)
- Karlstad Central Hospital (SE)
Publication Details
- Journal
- Journal of Internal Medicine
- Published
- 2025-04-06
- DOI
- https://doi.org/10.1111/joim.20085
- Citations
- 3
- Primary Topic
- Adrenal Hormones and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.88
Funders
- Karolinska Institutet
- Knut och Alice Wallenbergs Stiftelse
- Novo Nordisk
- Stockholms Läns Landsting
- Vetenskapsrådet
- Novo Nordisk Fonden